Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 3/20 | 0.37 |
| ▸ | PTPN6 | P29350 | 2/20 | 0.34 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA7 | P43166 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | EGFR | P00533 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21339804 | 0.91 | THRB (0.40) | PTPN1THRBCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL21339800 | 0.84 | CYP1A2 (0.38) | THRBCYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL20883275 | 0.83 | CYP1A2 (0.42) | THRBCYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL20883274 | 0.83 | CYP1A2 (0.42) | THRBCYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL21339801 | 0.83 | ACACB (0.40) | THRBCYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL21339807 | 0.82 | THRB (0.36) | PTPN1THRBCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL21339970 | 0.81 | PPARG (0.42) | THRBCYP3A4CYP2C9CYP2C19EGFR | |
| SCHEMBL21339976 | 0.79 | EGFR (0.32) | THRBCYP3A4EGFR | |
| SCHEMBL24827451 | 0.78 | CYP1A2 (0.40) | THRBCYP1A2CYP2C19CA1CA2 | |
| SCHEMBL19773579 | 0.78 | THRB (0.43) | THRBCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10907099-B2 | Compound, composition, cured object, optically anisotropic body, and reflective film | FUJIFILM CORPORATION (JP) | 2021-02-02 | — | — | US | disclosed |
| US-20190276743-A1 | COMPOUND, COMPOSITION, CURED OBJECT, OPTICALLY ANISOTROPIC BODY, AND REFLECTIVE FILM | FUJIFILM CORPORATION (JP) | 2019-09-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10907099-B2 | Compound, composition, cured object, optically anisotropic body, and reflective film | CFL1, ADCY10, ADCY1 | PTPN1 4121/4885PTPN6 4360/4885PTPN11 4303/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.